Fraud is Fraud (so, don’t blame telehealth)
On June 13th the U.S. Department of Justice (DOJ) announced a federal health care fraud indictment against the founder and CEO of Done Global Inc., as well as the company’s clinical president, alleging the individuals were conspiring to commit health care fraud, amongst other charges. The issue has put the currently waived in-person requirements related to controlled substance prescribing in the spotlight due to the fact that the company was focused around Adderall (which is a Schedule II controlled substance) and other stimulant prescribing via telehealth.